SupremeToday Landscape Ad
Back
Next
Judicial Analysis Court Copy Headnote Facts Arguments Court observation
Listen Audio Icon Pause Audio Icon
judgment-img

DELHI HIGH COURT
PRATHIBA M.SINGH
Sun Pharma Laboratories Ltd. – Appellant
Versus
Dabur India Ltd. – Respondent


Table of Content
1. challenge to trademark registry order (Para 3)
2. filing time limits and evidence rules (Para 4 , 5 , 6)
3. discretion to extend evidence filing period (Para 8 , 9)
4. hearing on merits and final order (Para 10 , 11)
5. stay on registration during examination (Para 13 , 14)

JUDGMENT

Prathiba M. Singh, J. (Oral)--This hearing has been done through hybrid mode.

I.A. 12673/2022 & I.A. 12674/2022 (for exemptions)

2. Allowed, subject to all just exceptions. Applications are disposed of.

C.A.(COMM.IPD-TM) 146/2022 & I.A. 12672/2022 (for stay)

3. This is an appeal filed under Section 91 of the Trade Marks Act, 1999 (hereinafter `Act') challenging the order of the Trademark Registry dated 21st July, 2022 dismissing opposition no.204995 of the Appellant/Opponent (hereinafter `Opponent') against trade mark application no.1309040 of Respondent No.1/Applicant (hereinafter `Applicant') for the mark `Dabur Glucorid KP (Label)' in class 5. Vide the said order, the extension of time sought by the Appellant for taking the evidence on record under Rule 50(3) of the Trade Marks Rules, 2002, (hereinafter `2002 Rules'), after delay in service of evidence to the Applicant, was rejected

Click Here to Read the rest of this document
1
2
3
4
5
6
7
8
9
10
11
SupremeToday Portrait Ad
supreme today icon
logo-black

An indispensable Tool for Legal Professionals, Endorsed by Various High Court and Judicial Officers

Please visit our Training & Support
Center or Contact Us for assistance

qr

Scan Me!

India’s Legal research and Law Firm App, Download now!

For Daily Legal Updates, Join us on :

whatsapp-icon telegram-icon
whatsapp-icon Back to top